Active structured domain · foundational corpus
Synthetic biology and cellular engineering
Molecular tools, cell systems, protocols, measurements, and safety boundaries represented with explicit experimental scope.
Primary stress point
Performance in a cell line, organoid, animal model, and human intervention are different evidence states and cannot be silently collapsed.
Canonical factory depth
23 of 23 governed factory records are active canonical releases. The foundational graph is fully public; higher-order hypotheses remain separately gated.
Canonical public layer
Records that passed the gate
Cell-line versus primary-cell evidence
A comparison boundary between immortalized or transformed model cells and donor-derived primary cells with different chromatin, state, and handling.
Inspect claims and provenance →
In-vitro versus in-vivo evidence
A hierarchy that keeps biochemical assays, cultured-cell experiments, animal studies, and human in-vivo observations as separate evidence states.
Inspect claims and provenance →
Off-target nomination versus confirmation
A distinction between assays that identify candidate sites and cellular measurements that confirm editing frequency under matched conditions.
Inspect claims and provenance →
Somatic versus germline genome editing
A boundary between edits confined to treated somatic cells and edits made in embryos or reproductive-line cells that may become heritable.
Inspect claims and provenance →
Adenine base editing
An evolved deaminase–Cas architecture that can install selected A-to-G outcomes without programmed DNA cleavage.
Inspect claims and provenance →
CRISPR-Cas9 nuclease editing
RNA-guided DNA cleavage using a Cas9 nuclease and target-complementary guide sequence.
Inspect claims and provenance →
Cytosine base editing
A Cas-guided deaminase architecture that can install selected C-to-T outcomes without a programmed double-strand break.
Inspect claims and provenance →
Genetic toggle switch
A synthetic mutually repressive gene network with two experimentally switchable stable expression states.
Inspect claims and provenance →
Prime editing
A genome-editing method coupling a Cas9 nickase–reverse-transcriptase fusion with a prime-editing guide RNA that identifies a target and encodes a desired edit.
Inspect claims and provenance →
Repressilator gene oscillator
A synthetic cyclic repression network designed to generate oscillatory gene-expression dynamics.
Inspect claims and provenance →
Editing efficiency and byproduct measurement
Joint measurement of intended sequence outcomes, indels, partial edits, bystanders, and other products in a defined sample.
Inspect claims and provenance →
Single-cell perturbation readout
Joint capture of perturbation identity and single-cell molecular state to resolve heterogeneous responses in a pooled experiment.
Inspect claims and provenance →
Targeted amplicon sequencing of edit outcomes
Locus-focused sequencing used to quantify intended edits, indels, and selected nominated off-target outcomes.
Inspect claims and provenance →
Double-strand-break repair outcomes
Cellular repair of a targeted DNA break through end joining, templated repair, and other context-dependent pathways.
Inspect claims and provenance →
Guide RNA and PAM recognition
The targeting mechanism that combines guide–DNA complementarity with protospacer-adjacent-motif recognition by Cas9.
Inspect claims and provenance →
Prime-editing guide RNA mechanism
A guide architecture that combines target recognition, primer binding, and an encoded reverse-transcription template.
Inspect claims and provenance →
Cell-free gene expression systems
Transcription and translation outside intact living cells using extracted or reconstructed biochemical machinery.
Inspect claims and provenance →
CHANGE-seq off-target nomination
An in-vitro circularized-genomic-DNA assay for high-throughput nomination of Cas9 cleavage activity.
Inspect claims and provenance →
Directed-evolution workflows
Iterative variation and selection procedures that couple a desired biomolecular activity to differential replication or survival.
Inspect claims and provenance →
Ex-vivo genome-editing workflow
A process in which cells are collected, edited and assessed outside the body, then returned under a clinical or experimental protocol.
Inspect claims and provenance →
Genome-editor delivery systems
Vehicles and formulations that transport genome-editor components to a defined cell population or tissue.
Inspect claims and provenance →
GUIDE-seq off-target detection
A cell-based sequencing method that captures double-strand oligonucleotides at nuclease-induced DNA breaks to nominate off-target sites.
Inspect claims and provenance →
In-vivo genome-editing workflow
A process that administers editor components directly so that delivery, editing, and biological response occur inside the participant or organism.
Inspect claims and provenance →
Pooled CRISPR screening
Parallel genetic perturbation using a guide library, selectable phenotype, and sequencing-based guide abundance readout.
Inspect claims and provenance →
Below the public line
Draft inventory remains private until canonical release.
The public surface exposes aggregate capacity only. Draft identifiers, titles, routes, claims, source packets, and review blockers are excluded from crawlable pages and registries.
Withheld records
1
Withheld typed edges
0
Domain contract
The registry exposes the boundary, not just the content.
Graph records
25
Typed edges
30
Public canonical
24
Withheld
1
Read the governing architecture in the Epistemic Publication System.